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Introduction
Bovine viral diarrhea virus (BVDV) is an economically impor-
tant pathogen of domestic livestock and wild ruminants. The vi-
rus is a member of the genus Pestivirus, which together with the 
Flavivirus and Hepacivirus genera constitute the family Flaviviridae 
(Van Regenmortel, 1999). The genome of BVDV is approximately 
12.3 kb in length and consists of a single long open reading frame 
(ORF) flanked by 5′ and 3′ nontranslated regions (NTRs) (Collett et 
al., 1988). Translation of the ORF is mediated by an internal ribo-
some entry site (IRES) (Poole et al., 1995). The ORF is translated into 
a single large polyprotein which is co- and post-translationally pro-
cessed into at least 11 mature structural and nonstructural (NS) vi-
ral proteins as follows: Npro-capsid (C)-Erns-E1-E2-p7-NS2-3-NS4A-
NS4B-NS5A-NS5B (Collett et al., 1988; Elbers et al., 1996; Tautz et al., 
1997). Npro is an autoprotease that cleaves at its own carboxyl-termi-
nus to release the C protein (Rumenapf et al., 1998). The cleavages of 
C, Erns, E1, E2 and p7 are catalyzed by host cellular signal peptidases 
(Rumenapf et al., 1993, 1998). The N-terminal, one-third of NS3 en-
codes a serine protease that functions in concert with cofactor NS4A 
to mediate processing of all downstream NS proteins (Collett et al., 
1988; Failla et al., 1994). BVDV isolates are divided into noncyto-
pathic (ncp) and cytopathic (cp) biotypes that are distinguished by 
their effect on cultured cells (Gillespie et al., 1960). Expression of NS3 
as a separate protein is a hallmark of cp-BVDV (Donis and Dubovi, 
1987). NS3 is co-linear to the C-terminal portion of NS2-3 and its ex-
pression by cp-BVDV is the result of complex genetic changes (Mey-
ers et al., 1996). However, an almost complete cleavage of NS2-3 in 
ncp-BVDV during the early hours of infection has been reported re-
cently, indicating that temporal modulation of NS2-3 processing is 
crucial for replication and pathogenicity (Lackner et al., 2004).
Genetic analyses have shown that genome replication requires 
the five NS proteins, NS3, NS4A, NS4B, NS5A and NS5B, of which 
only NS5A is complementable in trans (Grassmann et al., 2001; 
Moser et al., 1999; Tautz et al., 1999). The known relevant catalytic 
functions in this complex are the nucleotidyl transferase of NS5B 
(Lai et al., 1999; Steffens et al., 1999), as well as the ATPase and RNA 
helicase of NS3 (Grassmann et al., 1999). The roles of NS4A, NS4B 
and NS5A in RNA replication are unknown (Qu et al., 2001). Pesti-
virus virions are enveloped particles between 40–60 nm in diame-
ter. They consist of viral genomic RNA, the C protein, the envelope 
glycoproteins Erns, E1, and E2, as well as the lipid membrane enve-
lope. Electron microscopy of infected cells has suggested that parti-
cles bud into the lumen of cytoplasmic vesicular structures (Ohm-
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Abstract
A selective trans-packaging system was developed to produce and isolate bovine viral diarrhea virus (BVDV) pseudo-particles with com-
plementing reporter replicons and their packaging proteins expressed in trans with recombinant vaccinia virus. The encapsidation of repli-
con rNS3-5B was dependent not only on the in trans expression of structural proteins C, Erns, E1 and E2, but also the nonstructural proteins, 
p7 and contiguous precursor NS2-3-4A. Nonstructural p7, NS4B, NS5A or NS5B could be expressed in cis and in trans with precursor NS2-3-
4A without significantly affecting virion assembly efficiency. NS2-3-4A was identified as an in trans functional precursor in virion assembly. 
BVDV genomes with mutant NS5B, which did not undergo active replication, were packaged 5-fold less efficiently than the intact genomes 
demonstrating the importance of replication in virion packaging. These results suggest that genome replication and assembly are closely asso-
ciated, consistent with a model in which these two steps are coupled for maximum efficiency.
Keywords: BVDV, pseudo-particles, trans-packaging, complementation, NS2-3-4A precursor, replication, virion assembly
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ann, 1990). The mechanism by which genomic RNA is incorporated 
into virions during budding remains unknown. The spatial rela-
tionships between the sites of RNA replication and virion assem-
bly are not known and RNA packaging signals have not been iden-
tified in any of the Flaviviridae members. There is a growing body of 
evidence indicating that Pestivirus NS proteins participate in the as-
sembly of infectious virions (Agapov et al., 2004; Ansari et al., 2004). 
However, it is not known how the NS proteins contribute to the as-
sembly process. One possibility is that certain NS proteins partici-
pate in coupling the genome replication process to that of virion as-
sembly. The results described in this study demonstrate a significant 
involvement of NS proteins in genome packaging and also suggest 
that genome packaging is more efficient when coupled to an active 
replicase complex.
Results
Development of an efficient BVDV virion packaging assay system
We recently reported the development and use of a bicistronic 
replicon derived from the cp-BVDV strain NADL that expresses 
firefly luciferase to facilitate detection of its biological activity within 
electroporated cells (Ansari et al., 2004; Horscroft et al., 2005; Vas-
silev and Donis, 2000). This replicon, termed rNS3-5B, expresses 
the minimal complement of NS proteins required for genome rep-
lication (Ansari et al., 2004; Behrens et al., 1998). To study the role 
of NS proteins in BVDV genome packaging into virions, we con-
structed an additional reporter replicon, termed rp7-NS5B (Figure 
1A). The upstream cistron of this replicon expresses firefly lucifer-
ase and neomycin phosphotransferase, whereas the second cistron 
expresses the polyprotein encoding the complete set of NS proteins 
starting from p7 to NS5B, hence rp7-NS5B is approximately 1.5 kb 
longer than rNS3-5B. The expression of the second cistron is me-
diated by the encephalomyocarditis virus (ECMV) IRES. The RNA 
transcripts derived from both replicons resulted in the expression 
of increased levels of firefly luciferase following RNA electropor-
ation into bovine cells. Luciferase activity was detected as early as 
24 h post-electroporation and was maximal at 48 h (Figure 1B). Both 
replicons, rNS3-5B and rp7-NS5B, expressed equivalent levels of lu-
ciferase. In contrast, cells electroporated with rNS3-5Bgdd, showed 
only background levels of luciferase activity, indicating that the sig-
nificant levels of luciferase activity observed after rNS3-5B or rp7-
NS5B were dependent on the polymerase activity of NS5B to me-
diate RNA amplification (Figure 1B). More importantly, luciferase 
levels were found to correlate with the intracellular amounts of rep-
Figure 1. Replication and packaging of subgenomic BVDV replicons by helper virus. (A) Schematic diagram of bicistronic reporter BVDV repli-
cons rNS3-5B and rp7-NS5B as indicated: F-luc = firefly luciferase, Ubi = ubiquitin, Neo = neomycin phosphotransferase and EMCV = internal ri-
bosome entry site of EMCV. (B) Firefly luciferase activity from total cell lysates measured at the indicated hours post-electroporation (hpe) with 
RNA transcripts of rNS3-5B (filled square), rp7-NS5B (open triangle) and rNS3-5Bgdd (diamond), respectively. All values were normalized for 
electroporation efficiency by measuring the Renilla luciferase from a monocistronic RNA co-electroporated with the replicon RNA transcripts. 
Data represents one of the repeated experiments. (C) Northern blotting analysis to determine replication efficiency of rNS3-5B (lane 2), rp7-NS5B 
(lane 3) in NCL1 cells at the indicated hours (hrs) after electroporation with RNA transcripts. RNA derived from rNS3-5Bgdd served as a con-
trol (lane 1). Panel a shows replicon RNA in total cellular RNA extracted from 1 × 106 cells. Panel b is an image of the ethidium bromide stained 
agarose gel of total cellular RNA that was blotted and probed in panel a. (D) Transduction of luciferase expression to naïve (indicator) cells us-
ing supernatant collected from cells persistently infected by ncp-BVDV-2 helper virus for 36 h before electroporation with reporter BVDV replicon 
RNAs. Luciferase activities were tested 48 h post-RNA electroporation or infection with packaged/pseudotyped replicon RNAs. Packageable rep-
licons refer to replicons recovered from source cells transfected with RNA transcripts and used for the transduction of indicator cells. Transduced 
replicons refer to replicons recovered from indicator cells following inoculation with packaged replicons.
RepLicon trans-packaging ReveaLs nonstRuctuRaL pRoteins foR BvDv viRion   333
licon RNA as indicated by northern blot hybridization (Figure 1C). 
The luciferase levels from the BVDV replicons were normalized for 
electroporation efficiency by quantification of a co-electroporated 
RNA encoding Renilla luciferase. To this end, a fraction of the elec-
troporated cells was cultured separately in which Renilla luciferase 
activity was monitored at 4 h post-electroporation (data not shown). 
An excellent correlation was observed between normalized RNA 
levels as detected by northern blot analysis and normalized firefly 
luciferase expression at all time points analyzed (Figs. 1B, C). How-
ever, it appeared that the kinetics of RNA accumulation was slightly 
different between the two reporter replicons, with rNS3-5B RNA ac-
cumulation delayed relative to rp7-NS5B.
Previous studies have demonstrated that BVDV replicons can be 
packaged by infecting with helper BVDV virus, like the naturally-oc-
curring pestivirus defective interfering (DI) particles that they emu-
late (Behrens et al., 1998; Meyers and Thiel, 1995). To ascertain if the 
introduction of foreign RNA elements into the BVDV subgenomic 
RNA might interfere with its encapsidation, we electroporated the 
reporter replicon RNAs into helper BVDV genotype 2 (BVDV-2) in-
fected cells and analyzed the cell culture medium harvested 2 days 
after electroporation for its ability to transduce luciferase expres-
sion in bovine cells. The results revealed that both versions of re-
porter replicons were able to transduce luciferase expression in the 
indicator cell monolayer (Figure 1D) and there were no significant 
differences between the rNS3-5B and rp7-NS5B replicons in the re-
lease of virions into the culture fluids (Figure 1D). The levels of lu-
ciferase expression in the transduced cells were higher than in the 
electroporated cells. These results indicated that replicons rNS3-5B 
and rp7-NS5B retain the necessary cis-elements for packaging, al-
though it is not known if BVDV structural proteins can exclude for-
eign RNA molecules.
A recent report indicated that encapsidation of the BVDV ge-
nome was strictly dependent on the presence of the NS2-3 protein 
(Agapov et al., 2004). The finding that the two reporter replicons dif-
Figure 2. Packaging of BVDV replicons using recombinant vaccinia viruses expressing different lengths of BVDV proteins in trans. (A) Schematic 
representation of recombinant vaccinia virus genome expressing different lengths of BVDV proteins. The thymidine kinase (TK) gene of vaccinia 
virus WR was replaced with BVDV coding regions having truncations from the C-terminal end of the BVDV genome: T7 = T7 promoter, R = Ri-
bozyme of hepatitis D virus. Asterisk (*) with NS5B indicates the mutation of GDD motif to ATR. (B) Western blot analysis of NCL1 cells infected 
with recombinant vaccinia virus expressing different length of BVDV proteins. Total cell lysate corresponding to 2 × 104 NCL1 cells was loaded 
into each lane of an 8% SDS-PAGE gel, electrophoresed, transferred to a membrane and protein detected using monoclonal antibodies against E2 
(panel a) or NS3 (panel b). Lanes 1 to 5 represent NCL1 cells infected with recombinant vaccinia virus vT7-cpNgdd, vT7-ncpNgdd, vT7-ncpNS2-3, 
vT7-p7 and vT7-E2, respectively. Lane 6 is normal control cells while lane 7 represents NCL1 cells persistently-infected with ncp-BVDV. (C) Trans-
packaging of BVDV replicons using recombinant vaccinia virus vT7-ncpNgdd. NCL1 cells were infected with wild type (WR) or vT7-ncpNgdd 
vaccinia viruses after 36 h post-RNA electroporation of the two replicons. The trans-packaged replicon pseudo-particles from the cells were fil-
tered and applied onto naive cells. Luciferase activities were tested 48 h after electroporation or infection of replicons. White bars represent rep-
licon rNS3-5B, while gray bars represent replicon rp7-NS5B. A fraction of the supernatant was incubated with 100 serum neutralizing units of 
BVDV neutralizing antibody for 30 min at room temperature prior to infection of naive NCL1 cells. Data represents one of the repeated experi-
ments. (D) Semliki Forest virus replicons fail to be packaged by vaccinia virus vT7-ncpNADLgdd. NCL1 cells were electroporated with transcripts 
derived from SFV3-lacZ. Four hours post-RNA electroporation, cells were infected with vaccinia virus vT7-ncpNADLgdd and stained for expres-
sion of β-galactosidase after 8 h (panel a). The supernatant from these cells was collected 24 h post-RNA electroporation, passed through a 0.1 mm 
filter and applied to fresh NCL1 naive cells (indicator cells) and further analyzed for expression of β-galactosidase after 12 h (panel b).
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fering in the expression of NS2-3 were efficiently incorporated into 
particles in the presence of helper ncp-BVDV infection prompted us 
to determine the minimum complement of viral proteins required 
for the incorporation of the subgenomic reporter replicon into virus 
particles. To this end, we engineered a helper vaccinia virus expres-
sion system that could generate either the entire wt BVDV genomic 
RNA and efficiently encode the BVDV polyprotein in infected cells 
or any selected mutants of interest (e.g. deletion mutants or mu-
tants with BVDV polyprotein having a catalytically inactive NS5B) 
(Figure 2A). The engineered vaccinia viruses, vT7-NADL and vT7-
cpNgdd, expressed the entire polyprotein of BVDV in infected cells 
(Figure 2B) and nearly 100% of the cells were positive by indirect 
immunofluorescence staining using an anti-E2 monoclonal antibody 
(Mab) (data not shown). Western blot analyses of vT7-cpNgdd in-
fected cells revealed expression and correct processing of E2 and 
NS3 (Figure 2B). The vT7-NADL released infectious BVDV into the 
culture medium (data not shown).
To assess the efficiency of the complete set of BVDV proteins ex-
pressed by the vaccinia system in encapsidating BVDV reporter rep-
licons into functional viral particles, we analyzed the expression 
of luciferase in indicator cells inoculated with cell culture medium 
from the packaging cells, the rNS3-5B or rp7-NS5B RNA electropor-
ated cells following infection with the helper vT7-ncpNgdd recom-
binant vaccinia virus. The culture fluid from the packaging cells was 
passed through a 0.1 μm filter to remove the vaccinia virus and the 
filtered fluid inoculated onto a fresh monolayer of indicator cells 
to assess transduction of luciferase expression. Luciferase activity 
measured from the indicator cells revealed the delivery of the rep-
licon rNS3-5B and rp7-NS5B to the new monolayer (Figure 2C). De-
livery of the two packaged replicons have comparable efficiency. In 
contrast, wild type vaccinia virus WR could not trans-package the 
BVDV replicon, hence only background levels of luciferase activ-
ity were detected (Fig 2C). Furthermore the transduction of lucifer-
ase activity to the indicator cells was blocked by pre-incubation of 
the cell culture fluids with BVDV neutralizing Mabs against E2 (Fig-
ure 2C) indicating that the packaged replicon contained authentic 
BVDV E2 protein on the surface. Taken together, these results dem-
onstrate that the replicon RNAs were encapsidated and transduced 
luciferase expression in the target cells. These encapsidated virions 
were also able to pass through a 0.1 μm filter with which vaccinia 
virus virions were effectively excluded.
BVDV virion packaging machinery is highly selective
Although the packaging of the reporter replicon by trans-com-
plementing with recombinant BVDV-vaccinia appears to recapitu-
late the natural process of DI propagation, the mechanism responsi-
ble for packaging the RNA is still unknown. The efficiency of virus 
assembly would be enhanced by the selectivity of the genome pack-
aging machinery. Such selectivity should be correlated with the fail-
ure to encapsidate a non-cognate viral RNA genome that is present 
in abundant quantities within the cytoplasm of the packaging cells.
To demonstrate the selectivity of Pestivirus genome encapsida-
tion we chose to exploit an alphavirus replicon system due to the 
similarities between Togaviruses and Flaviviruses in terms of RNA 
replication and assembly (Strauss and Strauss, 1994). We used a 
Semliki Forest virus (SFV) alphavirus replicon (SFV3-lacZ, Invitro-
gen, Carlsbad, CA) that accumulates to high levels in electroporated 
cells (Liljestrom and Garoff, 1991). This replicon encodes the SFV NS 
polyprotein from the genomic promoter, as well as the Escherichia 
coli β-galactosidase (β-gal) reporter protein from a subgenomic pro-
moter (Liljestrom and Garoff, 1991). Preliminary studies showed 
that a SFV replicon replicated efficiently in several bovine cells after 
electroporation (data not shown). The SFV3-lacZ RNA transcripts 
Figure 3. Requirement of different sets of BVDV NS proteins to package rp7-NS5B and rNS3-5B replicons. NCL1 cells were infected with differ-
ent recombinant vaccinia virus 36 h after being electroporated with replicons (A) rp7-NS5B or (B) rNS3-5B. The trans-packaged replicon pseudo-
particles from RNA electroporated cells were filtered and applied to naive cells. Luciferase activities were measured 48 h after electroporation or 
infection of replicons.
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electroporated into bovine cells and infected with helper vT7-ncp-
NADLgdd or BVDV-2 directed the expression of high levels of β-ga-
lactosidase in the packaging cells (Figure 2D, panel a). However, no 
β-galactosidase could be detected in the indicator cells inoculated 
with the cell culture filtrates from RNA electroporated cells (Figure 
2D, panel b). These results indicated that the pestivirus packaging 
machinery has a strong selection for the RNA genome, although the 
packaging signals at the RNA level have not yet been defined.
Segregation of BVDV polyprotein expression between NS3 and NS4A 
leads to the failure of virion packaging
The results presented above validated the use of the recombinant 
vaccinia helper system to encapsidate and transduce BVDV repli-
cons. Previous studies had indicated that NS2, NS3, NS4A and NS5B 
played a role in the assembly of infectious virions (Agapov et al., 
2004; Ansari et al., 2004). To determine the minimum complement 
of viral proteins required in trans to package the rp7-NS5B RNA (ex-
pressing all the NS proteins) into infectious particles, we engineered 
a vaccinia virus vT7-E2 which expresses the BVDV structural pro-
teins, C, Erns, E1 and E2, with the autoprotease, Npro, at the N-termi-
nus of C to conserve the normal biogenesis of its N-terminus (Figure 
2A). The Npro is neither a component of virions, nor is it required 
for pestivirus virion assembly (Lai et al., 1999). Preliminary studies 
showed that vaccinia recombinants expressed and processed both 
E2 and NS2-3/NS3 as expected, due to the presence of signal se-
quences and the Jiv90 element, respectively (Lackner et al., 2006).
Our results indicate that vT7-E2 helper transduced replicon 
rp7-NS5B (luciferase) to target cells (Figure 3A). However, the effi-
ciency of this process was significantly lower compared to that of 
the vT7-ncpNADLgdd or vT7-cpNADLgdd helper packaged, sug-
gesting that some of the BVDV NS proteins contributed to efficient 
virion assembly. Therefore, we constructed and evaluated another 
vaccinia BVDV recombinant that expressed the structural proteins 
and p7 (vT7-p7). This helper vaccinia-BVDV recombinant yielded 
equivalent trans-packaging efficiency as the complete polyprotein 
from vT7-ncpNADLgdd or vT7-cpNADLgdd (Figure 3A). These re-
sults indicated that only the structural proteins are required in trans 
to package cognate replicons expressing all the NS proteins. The ef-
ficiency of the process is greatly enhanced by the addition of p7 to 
the polyprotein that gives rise to the structural proteins, suggest-
ing a possible interaction between E2 and p7 (role for the precursor 
E2-p7) in replicon packaging, and by extension, in the assembly of 
progeny virions during BVDV infections.
In contrast with the rp7-NS5B replicon, the rNS3-5B failed to be 
packaged by the structural proteins expressed under identical con-
ditions (Figure 3B). Furthermore, rNS3-5B failed to be packaged by 
helper expression of additional NS proteins, p7 and NS2-NS3 (Figure 
3B). The functionality of the complementing vT7-ncpNS2-3 recom-
binant vaccinia was demonstrated by packaging of the rp7-NS5B, 
suggesting that failure to package is not due to undetected muta-
tions within structural genes. Furthermore, a different version of re-
combinant vaccinia virus, vT7-cpNS3, expressing polyprotein Npro-
NS3 derived from cp-BVDV strain NADL, also failed to package 
Figure 4. Characterization of recombinant vaccinia viruses expressing truncated ncp-BVDV polyproteins and its utilization for packaging of rNS3-
5B and rp7-NS5B replicons. (A) Schematic representation of recombinant vaccinia virus genome expressing ncp-BVDV polyproteins. The thy-
midine kinase (TK) gene of vaccinia virus WR was replaced with different sizes of truncated BVDV polyprotein, respectively. T7 = T7 promoter, 
R = Ribozyme of hepatitis D virus. (B) NS4A amino acid sequences included in vaccinia virus vT7-NS4A, vT7-NS4AM (retained middle domain 
but deleted C-terminal) and vT7-NS4AN (retained only N-terminal). (C) The expression and processing of NS3 in cells infected with these re-
combinant vaccinia viruses. Cell lysate corresponding to 2 × 104 NCL1 cells were loaded in each lane of 8% SDS-PAGE and detection of NS3 
was performed by western blotting using a primary monoclonal antibody against NS3. Note NS4AN was not processed from NS2-3 in the vT7-
ncpNS4AN vaccinia construct.
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rNS3-5B (data not shown). Taken together, these results suggest that 
the polyprotein downstream of NS3 is involved in efficient packag-
ing of rNS3-5B.
It was surprising that vT7-cpNS3 could not trans-complement 
rNS3-5B for packaging. It is worth noting that the cells harboring 
the rNS3-5B replicon, expressed precursor NS3-NS4A-NS4B-NS5A-
NS5B that could be processed into functionally mature proteins. 
Similarly, recombinant vaccinia virus, vT7-cpNS3, expressed pre-
cursor Npro-Erns-E1-E2-p7-NS2-3 that could be processed by host cel-
lular signal peptidase. The two precursors overlap in the NS3 re-
gion, therefore, the cells harboring both rNS3-5B and vT7-cpNS3 
expressed two truncated polyproteins that covered the entire BVDV 
genome. We demonstrated that efficient trans-packaging of rNS3-5B 
could be achieved by co-infection with recombinant vaccinia virus 
vT7NADLgdd, which expresses the entire BVDV polyprotein with 
the GDD motif in NS5B mutated to null the replication activity (Fig-
ure 3B). Thus, the failure of rNS3-5B to be packaged by vT7-cpNS3 
indicated that contiguous expression of nonstructural proteins NS2-
3 with its downstream polyproteins is essential for the efficient in-
corporation of rNS3-5B into functional virus particles.
Contiguous expression of NS2-3-4A is essential for efficient virion 
packaging
To identify the critical NS proteins responsible for the failure to 
incorporate rNS3-5B genomes into virion particles, we analyzed 
their packaging using a recombinant vaccinia virus that expressed 
the structural proteins with the NS protein segment, p7-NS4A or p7-
NS5A, as a single polyprotein derived from ncp-BVDV (Figure 4A). 
Western blotting showed that all the vaccinia recombinants expressed 
and processed E2 and NS2-3 proteins correctly (Figure 4C, lanes 4, 5, 
6). Recombinants vT7-NS4B, vT7-NS5A and vT7-NS4A packaged the 
rNS3-5B replicon with equivalent efficiency to that of rp7-NS5B, re-
spectively (Figs. 5A, B). These results indicate that all of the proteins 
upstream of, and including NS4A could be provided in trans for effi-
cient virion packaging. However, we have demonstrated that rNS3-
5B could not be efficiently trans-packaged by recombinant vaccinia vi-
rus expressing polyprotein Npro-NS3. The packaging efficiency of the 
rNS3-5B replicon by complementation with vT7-NS4A was compara-
ble with vT7-NS4B, vT7-NS5A and vT7-Ngdd (Figs. 5A, B). These re-
sults suggest that the sequence context downstream of NS4A is not 
essential for NS2-3-4A processing or complex formation. However, 
we could not exclude the possibility of involvement of the polyprot-
ein, NS4B-5B region, in virion packaging (Ansari et al., 2004).
The C-tail of NS4A is indispensable for efficient virion packaging
The most significant role of NS4A is to function as a cofactor in the 
NS3-mediated cleavage of the viral polyproteins (Tautz et al., 2000; 
Xu et al., 1997). Because the central domain of NS4A is critical for 
this function, we engineered a C-terminal deletion NS4A mutant, 
vT7-NS4AM, and another mutant lacking both the C-terminal do-
main and the middle domain of NS4A, vT7-NS4AN. The hydropho-
bic N-terminus of NS4A is predicted to adopt a helix conformation, 
which is likely to insert itself into membranes (Figure 4B). Western 
blotting results showed that NS2-3 was processed efficiently from its 
NS4AM precursor (Figure 4C, lane 3). It is important to note that the 
NS2-3-4AN precursor expressed from vT7-NS4AN was larger than 
the normal NS2-3 molecule by  2.2 kDa, indicating that the N-ter-
minal domain of NS4A molecule was retained with NS2-3 precursor 
(Figure 4C, lane 2). Both replicons, rNS3-5B and rp7-NS5B, were ef-
ficiently packaged by the recombinant vaccinia virus, vT7-ncpNS4A 
(Figure 5B). However, none of the vaccinia virus recombinant NS4A 
deletion mutants, vT7-NS4AN and vT7-NS4AM, were able to com-
plement packaging of the rNS3-5B replicon (Fig 5B). A summary of 
the packaging of the two replicons with different recombinant vac-
cinia virus mutants is given in Table 1. These findings suggest that 
the C-tail of NS4A is indispensable for efficient virion packaging.
The close link between BVDV virion packaging and replication machinery
Our results correlate with recent findings on the involvement of 
several NS proteins in the packaging of genomes generated by an ac-
tive viral replicase complex (Agapov et al., 2004; Ansari et al., 2004). 
Furthermore, Agapov et al., 2004 demonstrated the importance of 
the NS2-3 precursor in the production of infectious virions, although 
NS2 was dispensable for genome replication (Agapov et al., 2004). 
Taken together with the results presented above, the role of NS2 
and NS2-3 precursors may involve the engagement of the replicase 
Figure 5. Mapping of minimum sets of nonstructural polyproteins re-
quired for trans-packaging of rNS3-5B. NCL1 cells were infected with 
different recombinant vaccinia viruses 36 h after being electropor-
ated with replicon rNS3-5B or rp7-NS5B. The trans-packaged replicon 
pseudo-particles from the packaging cells were filtered and passed to 
naive cells. Luciferase activities in packaging cells and indicator cells 
were measured 48 h after electroporation or infection of replicons. 
White bars represent replicon rNS3-5B, while gray bars represent rep-
licon rp7-NS5B. (A) Mapping of the nonstructural polyproteins re-
quired for trans-packaging of rNS3-5B and rp7-NS5B replicon using 
vT7-ncpNS4B, vT7-ncpNS5A and vT7-ncpNS5B in trans. (B) Map-
ping of the nonstructural polyproteins required for trans-packaging of 
rNS3-5B and rp7-NS5B replicon using vT7-ncpNS2-3, vT7-ncpNS4AN, 
vT7-ncpNS4AM and vT7-ncpNS4A in trans.
Table 1. Summary of BVDV replicon trans-packaging results with dif-
ferent recombinant vaccinia viruses expressing different lengths of 
BVDV polyproteins.
 rp7-NS5B rNS3-5B
vT7-E2 + −
vT7-p7 + −
vT7-ncpNS2-3 + −
vT7-ncpNS4AN + −
vT7-ncpNS4AM + −
vT7-ncpNS4A + +
vT7-ncpNS4B + +
vT7-ncpNS5A + +
vT7-ncpNgdd + +
vT7-cpNgdd + +
Replicon rp7-NS5B contains BVDV polyprotein from p7 to NS5B, 
while rNS3-5B contains polyprotein from NS3 to NS5B. Recombinant 
vaccinia viruses express BVDV polyproteins from Npro to E2, p7, NS3, 
NS4A N-terminus, NS4A middle domain, NS4B, NS5A, NS5B, respec-
tively. +: packageable; −: unpackageable.
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complex by the structural proteins. To examine the recognition of 
the replication machinery by the structural proteins, we analyzed the 
production and release of virions by recombinant vaccinia virus car-
rying the WT BVDV genome and the BVDV genome having an in-
active NS5B. Cells were infected with these recombinant vaccinia vi-
ruses and culture supernatants collected at 16 h post-infection. Total 
cell lysates and culture supernatants were analyzed by western blot 
analysis to assess the levels of BVDV E2 protein expression in infected 
cells and supernatant which will indicate the virion released into the 
media. Fractions that co-sedimented with standard BVDV infectious 
virions (density 1.12 to 1.14) were found to contain detectable E2 (Fig-
ure 6, lane 6) and to be infectious to bovine cells (data not shown).
The relative amounts of E2 present in the culture supernatant of 
cells infected with vaccinia virus recombinants expressing wt NS5B or 
the catalytically inactive NS5Bgdd were determined by densitometry 
and normalized by the relative amounts of total E2 expressed in the 
infected cells. Vaccinia-derived BVDV genomes with inactive NS5B 
but otherwise normal polyprotein, released only 20% of the virions 
compared to the cells infected with vT7-cpNADL (Fig 6, lanes 5 and 
6). Furthermore, the virion produced by vT7-cpNgdd were noninfec-
tious in bovine cells (data not shown). On the other hand the amount 
of expressed E2 in vT7-Ngdd infected cells (lane 2) was slightly 
greater than the vT7-cpNADL (lane 3). This difference may be due to 
the fact that in vT7-cpNADL infected cells, part of the E2 is used for 
authentic virion production, while in vT7-cpNgdd infected cells most 
of the E2 is retained inside the cells. It was also evident that viral ge-
nome replication in vT7-cpNADL infection did not lead to increased 
production of E2 inside the cells (lane 3) as compared to vT7-cpNgdd 
(lane 2) due to the production of high levels of transcripts generated 
by vaccinia infection. Hence, the expressed protein from viral repli-
cation is masked by expression products derived from vaccinia tran-
scripts. These results strongly suggest that active genome replication 
enhances the production and/or release of virions and are also 
consistent with the previous report where involvement of the 
NS5B in genome packaging is demonstrated (Ansari et al., 2004).
Discussion
We have developed an efficient BVDV reporter replicon packag-
ing system, in which both the minimum replicon, rNS3-5B, and the 
long replicon, rp7-NS5B, replicated and assembled with comparable 
efficiency. We employed a recombinant vaccinia virus system to ex-
press the BVDV packaging proteins rather than a BVDV helper virus 
or dual replicon approach (Agapov et al., 2004). The pure progeny 
BVDV virions can be easily separated from recombinant vaccinia vi-
rions by filtration. The efficiency of the trans-packaging system us-
ing recombinant vaccinia virus expressing polyprotein from Npro to 
NS4A is comparable to that using a helper BVDV virus, which oc-
curs in nature. Furthermore, the introduction of recombinant vac-
cinia virus during the late stages of BVDV replicon replication min-
imizes viral recombination opportunity. Our unpublished data has 
shown that a chimeric BVDV genome up to 15 kb in length could 
be efficiently assembled into infectious virions. Therefore, the rela-
tively large cloning capacity of the replicons accommodates differ-
ent purposes. The desired heterologous genes could be effectively 
cloned into the firefly luciferase or neomycin phosphotransferase 
gene position. Thus, this replicon trans-packaging system can serve 
as a gene delivery system at the cellular or animal level.
Consistent with our results, Agapov et al. (2004) reported that un-
cleaved NS2-3 was required for the production of infectious BVDV. 
Both, the system used by Agapov et al. (2004) and our system dem-
onstrated the importance of the expression of NS4A in cis with NS2-
3 protein. In contrast to our results, Agapov et al. (2004) determined 
that the expression of NS4A in cis with NS2-3 was not essential for, 
but markedly increased the packaging efficiency. This difference 
may be due to the different packaging systems used in the stud-
ies. Agapov et al. (2004) used a second BVDV replicon to express the 
functional NS2-3-4A in trans, while we used a recombinant vaccinia 
virus to express the functional NS2-3-4A in trans. This may result in 
different protein localization and different packaging efficiencies.
High levels of NS3 are expressed by cp-BVDV which is well cor-
related with an enhanced accumulation of intracellular viral RNA 
as compared to ncp-BVDV strains (Lackner et al., 2004). However, 
virion production from cp-BVDV is not significantly different than 
that from ncp-BVDV in tissue culture. This indicated that a greater 
level of viral genome and packaging proteins were not enough for 
increased virion production. It has been demonstrated that NS2-3 
was involved in virion assembly. However, it was surprising that 
expression of NS2-3-4A, but not NS2-3, could complement replicon 
assembly in our packaging system, suggesting that the NS2-3-4A 
precursor was involved in virion assembly. We also observed that 
extending NS2-3-4A to NS2-3-4A-NS4B or NS2-3-4A-NS4B-NS5A 
did not increase the packaging efficiency of rNS3-5B. This demon-
strated that the region downstream of NS4A could be separated 
from NS2-3-4A for assembly function.
Thus, the contiguous expression of Npro-Erns-E1-E2-p7-NS2-3 
with NS4A contributes to the successful trans-packaging of rNS3-
5B. A previous report suggested that p7 could be separated from E2 
and NS2 with efficient virion packaging (Harada et al., 2000). There-
fore, our results indicate that the contiguous expression of NS2-3-
4A is essential for efficient trans-packaging of rNS3-5B. Based on the 
information that NS3 cannot be functionally replaced by uncleaved 
NS2-3, as well as, the strict correlation between NS3 level and effi-
ciency of RNA replication (Lackner et al., 2004), this strongly sug-
gested that NS3, but not NS2-3, is an essential component of the vi-
ral replication complex. Thus, we propose that precursor NS2-3-4A, 
provided by the recombinant vaccinia viruses, was involved in effi-
cient virion trans-packaging but not virus replication.
Having shown the importance of the NS2-3-4A precursor protein, 
we suggest that cp-BVDV also employs this precursor for the virion 
assembly function. Thus, pestiviruses exploit polyprotein precursors 
Figure 6. Lack of genome replication is correlated with reduced ef-
ficiency of virion assembly and release. RK-13 cells were infected 
with both T7 helper vaccinia virus vTF7-3 and vT7-cpNADL or vT7-
cpNgdd, respectively. The supernatant which contains both rVV and 
BVDV virions was filtered through 0.1 mm filter and centrifuged to 
pellet the virions. The infected cell lysates and virion pellets were re-
solved on 8% SDS-PAGE and western blot analysis was performed us-
ing a monoclonal antibody against BVDV E2. Lanes 1–3 represent cell 
lysates from the infected cells with vTF7-3, vTF7-3 + vT7-cpNgdd and 
vTF7-3 + vT7-cpNADL, respectively, while lanes 4–6 indicate the su-
pernatant from their corresponding infected cells.
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for different viral functions. The temporal regulation of NS2-3-4A au-
toprocessing is likely necessary for the switch between the phases of 
highly active viral RNA replication and virus morphogenesis. The 
processing speed, order and ratio of the polyprotein precursor may 
regulate different stages of the BVDV life cycle, i.e. translation, repli-
cation and assembly. Although we did not provide evidence for a di-
rect role of the NS proteins in the recruitment of actively replicating 
genomic RNA to assembly sites, the involvement of the NS proteins 
in virion assembly provides an obvious candidate.
Materials and methods
Viruses, cells and reagents
Rabbit kidney (RK13, CCL-37), monkey kidney (CV1, CCL-70), 
and thymidine kinase-deficient human osteosarcoma (TK-143B, 
CRL-8303) cells were obtained from the American Type Culture 
Collection (Manassas, VA). Bovine uterine cells (NCL1) and mono-
clonal antibodies against BVDV proteins were gifts from Dr. Ed-
ward Dubovi (Cornell University, Ithaca, NY). BVDV genotype 1 
(BVDV-1) isolate NADL (cytopathogenic) and vaccinia virus strain 
WR were obtained from the American Type Culture Collection. 
BVDV genotype 2 (BVDV-2) isolate 890 was a gift from Dr. Julia 
Ridpath (USDA, Ames, IA). Recombinant vaccinia virus produc-
ing the T7 RNA polymerase (vTF7-3) was a gift from Dr. Bernard 
Moss (NIH, Bethesda, MD). DNA restriction/modification en-
zymes and luciferase assay systems were purchased from Promega 
(Madison, WI). Fetal bovine serum (FBS), γ-irradiated FBS (γ-FBS), 
equine serum, antibiotics for tissue culture (penicillin and strep-
tomycin premix), minimum essential medium (MEM), Dulbecco’s 
MEM (DMEM) and oligonucleotides were purchased from Invitro-
gen (Carlsbad, CA). The NCL1 cells were grown in MEM supple-
mented with penicillin–streptomycin and 10% equine serum, while 
CV1 and TK-143B cells were grown in DMEM supplemented with 
penicillin and 10% FBS. All cells were maintained at 37 °C with 5% 
CO2. Plasmids encoding the full-length BVDV NADL genome and 
its derivatives lacking the Jiv cellular insert that mediates cyto-
pathogenicity (Rinck et al., 2001) were described previously (Vas-
silev et al., 1997). A plasmid that allows transcription of RNA mol-
ecules encoding Renilla luciferase with expression driven by the 
encephalomyocarditis virus (EMCV) IRES was described previ-
ously (Ansari et al., 2004).
Construction of bicistronic subgenomic BVDV reporter replicons
Bicistronic reporter replicons, rNS3-5B and rNS3-5Bgdd, were 
derived from the pNADLp15 full-length infectious genome of the 
BVDV strain NADL described previously (Ansari et al., 2004; Vas-
silev et al., 1997). Compared to rNS3-5B, rNS3-5Bgdd has a disabled 
NS5B by virtue of replacing the conserved GDD motif (amino acid 
residues 447 to 449, using NS5B numbering) with ATR (Ansari et al., 
2004). Another replicon, rp7-NS5B, was constructed as described for 
rNS3-5B, with the EMCV IRES inserted upstream of p7 rather than 
NS3. The junction between Npro and p7 consisted of a stretch of nu-
cleotides encoding for short amino acid segments of the N- and C-
termini of capsid (C) protein, to mediate the correct membrane tar-
geting of p7 and its subsequent processing. To this end, the central 
domain of the capsid (nucleotides 909–1079, encoding amino acids 
175–232 of the wt virus polyprotein) (Genbank accession AJ133738) 
was deleted by overlap extension PCR.
Construction of recombinant vaccinia viruses expressing BVDV viral 
proteins
Construction of recombinant vaccinia viruses by homologous re-
combination between a transfer plasmid carrying BVDV sequences 
and the vaccinia virus WR genome was performed as previously de-
scribed (Ausubel et al., 1989). The cloning sites in the vaccinia trans-
fer plasmid were flanked by the vaccinia virus DNA sequences, TKL 
(left) and TKR (right). Different sizes of the BVDV truncated poly-
proteins were first cloned into the vaccinia transfer vector, pSC59 
(Ausubel et al., 1989). The transfer vectors were engineered to con-
tain a T7 promoter with a transcription start site at nucleotide 1 of 
the BVDV genome that contained either full-length BVDV genome 
cDNA or deletions in the 3′ end of the open reading frame to gen-
erate C-terminal truncated BVDV polyproteins. All constructs con-
tained an intact BVDV 3′ UTR immediately followed by the hepatitis 
D virus ribozyme to yield a genuine BVDV 3′ end.
Vaccinia recombinants were generated in CV1 cells by trans-
fecting with the transfer plasmid DNA followed by infection with 
vaccinia virus WR. Selection of recombinant vaccinia viruses lack-
ing functional TK was performed by passage in TK−143B cells in the 
presence of 5-bromodeoxyuridine (BrdU). Candidate recombinant 
viruses were co-infected with vTF7-3 helper virus followed by the 
detection of BVDV E2 protein expression in infected CV1 cells us-
ing indirect immunofluorescence microscopy and a specific mouse 
monoclonal antibody against E2. The plaques expressing BVDV E2 
were purified three times and the expression and proper processing 
of all the structural and NS proteins was confirmed by western blot-
ting. The resulting recombinant vaccinia viruses (rVV) were termed 
vT7-cpNADL, which expresses the full-length BVDV genomic RNA 
(from the cpNADL strain) and vT7-cpNgdd, which expresses the 
full-length BVDV genomic RNA of cpNADL with the GDD motif 
of NS5B mutated to ATR. Analogous vaccinia virus recombinants, 
termed vT7-ncpNADL and vT7-ncpNgdd encode BVDV genomes 
that differ from the previous ones in their NS2 protein lacking the 
insert of bovine origin. Additional rVV were generated to express 
truncated versions of the BVDV polyprotein namely: vT7-E2, vT7-
p7, vT7-ncpNS2-3, vT7-ncpNS4AN, vT7-ncpNS4AM, vT7-ncpNS4A, 
vT7-ncpNS4B, and vT7-ncpNS5A. These viruses express the ncp-
BVDV NADL strain polyprotein spanning from Npro to E2, p7, NS3, 
NS4A N-terminus, NS4A middle domain, NS4A, NS4B and NS5A, 
respectively.
In vitro RNA transcription and electroporation
DNA templates for in vitro transcription were produced by PCR 
amplification of the region containing the T7 promoter and the en-
tire replicon of the relevant plasmids using Klentaq polymerase 
(Clontech BD Biosciences, Palo Alto, CA). In vitro RNA transcrip-
tion was performed using the T7-MEGAscript kit (Ambion, Austin, 
TX) as described previously (Ansari et al., 2004). The pIRES-Renilla 
plasmid was linearized with XbaI enzyme and used for RNA tran-
scription as described previously (Ansari et al., 2004). At all times 
the electroporation efficiency of the replicon RNA was monitored 
by co-electroporation of a reporter RNA encoding Renilla lucifer-
ase in which the expression was driven by the EMCV IRES. Correc-
tions for electroporation efficiency were not necessary due to the re-
peatedly consistent levels of Renilla luciferase expression (105 RLU) 
in each experiment.
RNA transcripts from a Semliki Forest Virus replicon, encod-
ing β-galactosidase (pSFV3-LacZ) (Invitrogen, Carlsbad, CA), were 
prepared using plasmid DNA linearized with SpeI. Capped RNA 
transcripts were synthesized in vitro with SP6-polymerase in the 
presence of m7G(5′)ppp(5′)G cap analog by using the mMessage 
mMachine kit (Ambion, Austin, TX). RNA concentration following 
transcription reactions was determined fluorometrically using Ribo-
green (Molecular Probes, Eugene, OR). An aliquot of the transcrip-
tion reaction was analyzed by formaldehyde agarose gel electro-
phoresis to determine the integrity of the transcripts. Transcription 
reactions were stored at − 80 °C in small aliquots for electroporation 
purposes.
NCL1 cells (70 to 80% confluent) were trypsinized, washed two 
times with ice-cold DMEM and resuspended at a concentration of 
2 × 107 cells/ml in cytomix as described previously (Ansari et al., 
2004). Briefly, transcripts (2 μg) were electroporated into 2 × 106 
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NCL1 cells in a 100 μl volume using a 0.2 cm gap cuvette with a sin-
gle electrical pulse discharge of 235 V, 100 μF and 48 Ohms. Repli-
cation of the electroporated RNA was quantified by northern blot 
analysis of cells harvested at various times post-electroporation as 
described previously (Ansari et al., 2004). Electroporation experi-
ments were repeated a minimum of three times, starting from inde-
pendent in vitro RNA synthesis reactions.
Reporter assays
Firefly and Renilla Luciferase assays were performed using the 
Dual Luciferase Assay system (Promega, Madison, WI) following 
the manufacturer’s protocol. Briefly, the NCL1 cells were harvested 
and lysed in lysis buffer. An equivalent of 1 × 105 cells was used for 
the measurement of luciferase enzyme activity. Light emission was 
measured using a TopCount Luminescence Counter (Packard In-
struments, Meriden, CT). To detect expression of β-galactosidase in 
transfected cells, monolayers were fixed with 0.2% paraformalde-
hyde in PBS for 5 min at room temperature. After 3 washes in PBS, 
the cells were incubated in a chromogenic substrate solution con-
taining 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-13-d-galactopy-
ranoside), 5 mM potassium ferricyanide, 5 mM potassium ferrocy-
anide and 2 mM MgCl2 in PBS. The appearance of blue color in the 
cell monolayers was monitored following incubation at 37 °C. Im-
ages were captured using wide-field digital photomicroscopy at 6-
hour intervals for a period of 24 h.
Infections with recombinant vaccinia viruses, BVDV or packaged replicons
Bovine cell monolayers were rinsed with PBS and inoculated 
with cell culture fluids containing vaccinia recombinants, BVDV 
or packaged replicon virions in a volume sufficient to cover the en-
tire cell monolayer. After adsorption for 1 h at 37 °C the superna-
tant was removed, monolayer rinsed and supplemented with pre-
warmed complete media and incubated in a 37 °C incubator until 
further analysis.
Western blotting
NCL1 cells (~ 80% confluency) were infected with each recombi-
nant vaccinia virus (multiplicity of infection, MOI = 5) together with 
T7 helper vaccinia virus (MOI = 3) to achieve a greater level of ex-
pression. Total cell lysates were collected 12 h after vaccinia infec-
tion while ncp-BVDV or cp-BVDV-infected cells were harvested at 
24 h post-infection. Cell lysate, the equivalent of ~ 2 × 104 cells, was 
loaded into each well of an 8% SDS-PAGE gel. Proteins were sepa-
rated and electrotransferred to nitrocellulose membranes (Hybond-
C, Amersham, Arlington Heights, IL). Proteins were detected using 
monoclonal antibodies against E2 (Antibody #4b6) or NS3. Anti-
body binding was detected using a chemiluminescent assay as de-
scribed before (Ansari et al., 2004).
Trans-packaging of BVDV replicons following infection with either 
recombinant vaccinia viruses expressing BVDV proteins or with BVDV-2
Approximately 2 μg of replicon RNA transcript and 0.4 μg of Re-
nilla reporter RNA were mixed and electroporated into 2 × 106 NCL1 
cells. Aliquots of the transfected cells, termed the packaging cells, 
were evenly distributed into ten fractions and plated in a 12-well-
plate. One well was harvested for luciferase activity at 48 h post-
electroporation to quantify the levels of packageable replicon RNA 
in the electroporated cells. The remaining nine wells were used for 
infection with recombinant vaccinia viruses expressing BVDV pro-
teins or with BVDV-2 at 36 h post-electroporation. A system that 
employs a dual vaccinia T7 promoter–T7 RNA polymerase co-in-
fection was used to express BVDV RNA (Fuerst et al., 1987). To this 
end, cells previously electroporated with replicon RNA were co-in-
fected with the recombinant vaccinia viruses expressing BVDV un-
der T7 promoter control (MOI = 5) and vTF7-3 recombinant vac-
cinia virus constitutively expressing T7 RNA polymerase (MOI = 1). 
The cells were incubated for an additional 24 h after which the me-
dium containing packaged replicons was harvested, passed through 
a 0.1 μm filter, reducing the helper vaccinia virus titer to undetect-
able levels and stored at 4 °C for further use. To assess the presence 
of packaged replicons, the culture filtrates (0.5 ml) were used to in-
oculate fresh NCL1 cells in duplicate (termed indicator cells) in 12-
well plates. The indicator cells were cultured for 48 h and harvested 
to measure luciferase activity as a reporter of the number of pack-
aged replicons delivered to the indicator cells by functional virions.
Virion release from cells infected with recombinant vaccinia virus express-
ing wt or replication-incompetent BVDV genome
The RK-13 rabbit kidney cells (~ 5 × 105) were co-infected with 
vTF7-3 (MOI = 3) and vT7-cpNADL or vT7-cpNgdd (MOI = 5), for 
1 h at 37 °C. The infected cells were rinsed with PBS and cultured 
in DMEM containing 2.5% γ-irradiated FBS for an additional 22 h. 
To investigate the presence of released BVDV virions, culture fluids 
were collected and centrifuged at 13,000 g for 15 min at 4 °C to re-
move cell debris and the supernatant filtered through a 0.1 mm fil-
ter to remove the vaccinia virions. The filtrate was then centrifuged 
using a 10% sucrose cushion and the fraction containing BVDV viri-
ons (density of 1.12 to 1.14) was collected and analyzed by western 
blotting as described above. The infected cell monolayer was har-
vested in SDS-PAGE sample buffer for subsequent analysis by west-
ern blotting to determine the relative structural protein expression 
levels in the different samples.
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